Novartis Ag (NVS) Other Non-Current Assets (2017 - 2025)
Novartis Ag (NVS) has disclosed Other Non-Current Assets for 9 consecutive years, with $509.0 million as the latest value for Q4 2025.
- Quarterly Other Non-Current Assets fell 85.48% to $509.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $509.0 million through Dec 2025, down 85.48% year-over-year, with the annual reading at $509.0 million for FY2025, 85.48% down from the prior year.
- Other Non-Current Assets hit $509.0 million in Q4 2025 for Novartis Ag, down from $3.5 billion in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $3.5 billion in Q4 2024 to a low of $275.0 million in Q4 2021.
- Historically, Other Non-Current Assets has averaged $1.3 billion across 5 years, with a median of $1.1 billion in 2022.
- Biggest five-year swings in Other Non-Current Assets: surged 303.64% in 2022 and later tumbled 85.48% in 2025.
- Year by year, Other Non-Current Assets stood at $275.0 million in 2021, then soared by 303.64% to $1.1 billion in 2022, then increased by 8.02% to $1.2 billion in 2023, then skyrocketed by 192.33% to $3.5 billion in 2024, then crashed by 85.48% to $509.0 million in 2025.
- Business Quant data shows Other Non-Current Assets for NVS at $509.0 million in Q4 2025, $3.5 billion in Q4 2024, and $1.2 billion in Q4 2023.